Smith & Nephew plc (SNN)
30.05
-0.21
(-0.69%)
USD |
NYSE |
May 07, 16:00
30.27
+0.22
(+0.73%)
Pre-Market: 08:28
Smith & Nephew Research and Development Expense (Annual) : 294.69M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Autolus Therapeutics Plc | 128.59M |
| Biodexa Pharmaceuticals Plc | 5.026M |
| Akari Therapeutics Plc | 2.822M |
| NuCana Plc | 16.79M |
| Mereo BioPharma Group Plc | 17.81M |